April 30, 2013
A California federal judge on Monday dismissed a suit alleging Amgen Inc. hired a "competitive intelligence" consulting firm to steal trade secrets about Teva Pharmaceuticals USA Inc.'s generic versions of blood drugs, finding Teva had no factual basis for its misappropriation claim.